Global Market Sentiment and Risk Appetite: The ongoing Middle East conflict and its potential impact on global growth and oil prices can influence overall market risk appetite. As a clinical-stage biotechnology company, AVBP is particularly sensitive to investor sentiment, with positive geopolitical news potentially leading to rallies.

Biotechnology Sector-Specific Funding and Investment Trends: Given AVBP is a clinical-stage company, its growth and operational runway are heavily dependent on successful public offerings, venture capital, and overall investor confidence in the biotech sector. A recent $75 million public offering highlights this reliance on capital markets.

US Economic Health and Inflation Outlook: A robust US economy, evidenced by strong job growth and stable unemployment, generally fosters investor confidence. However, any signs of escalating inflation could lead to tighter monetary policies and higher interest rates, which may increase the cost of capital for growth-oriented biotech firms like AVBP.